390 related articles for article (PubMed ID: 9280321)
1. Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect.
Castillo R; Escolar G; Monteagudo J; Aznar-Salatti J; Reverter JC; Ordinas A
Transfusion; 1997 Aug; 37(8):785-90. PubMed ID: 9280321
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic effect of platelet von Willebrand factor.
Castillo R; Escolar G; Monteagudo J; Reverter JC; Ordinas A
Haemostasis; 1992; 22(5):233-5. PubMed ID: 1478532
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients.
Castillo R; Monteagudo J; Escolar G; Ordinas A; Magallón M; Martín Villar J
Blood; 1991 May; 77(9):1901-5. PubMed ID: 1902120
[TBL] [Abstract][Full Text] [Related]
4. DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor.
Cattaneo M; Moia M; Delle Valle P; Castellana P; Mannucci PM
Blood; 1989 Nov; 74(6):1972-5. PubMed ID: 2508791
[TBL] [Abstract][Full Text] [Related]
5. Role for platelet von Willebrand factor in supporting platelet-vessel wall interactions in von Willebrand disease.
Castillo R; Escolar G; Monteagudo J; Ordinas A; Garrido M; Moia M; Federici AB; Mannucci PM
Am J Hematol; 1989 Jul; 31(3):153-8. PubMed ID: 2787114
[TBL] [Abstract][Full Text] [Related]
6. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.
Nichols TC; Samama CM; Bellinger DA; Roussi J; Reddick RL; Bonneau M; Read MS; Bailliart O; Koch GG; Vaiman M
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2455-9. PubMed ID: 7708664
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand's disease: case report and review of literature.
Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease.
Cattaneo M; Federici AB; Lecchi A; Agati B; Lombardi R; Stabile F; Bucciarelli P
Thromb Haemost; 1999 Jul; 82(1):35-9. PubMed ID: 10456451
[TBL] [Abstract][Full Text] [Related]
9. In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma.
d'Alessio PA; Castaman G; Rodeghiero F; de Boer HC; Federici AB; Mannucci PM; de Groot PG; Sixma JJ; Zwaginga JJ
Thromb Res; 1992 Jan; 65(2):221-8. PubMed ID: 1579897
[TBL] [Abstract][Full Text] [Related]
10. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
Shihong I; Morris D; Konkle BA
Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
12. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
Castaman G; Federici AB; Rodeghiero F; Mannucci PM
Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
[TBL] [Abstract][Full Text] [Related]
13. Platelet von Willebrand factor.
Gralnick HR; Williams SB; McKeown LP; Magruder L; Hansmann K; Vail M; Parker RI
Mayo Clin Proc; 1991 Jun; 66(6):634-40. PubMed ID: 2046403
[TBL] [Abstract][Full Text] [Related]
14. In vivo interaction of von Willebrand factor with platelets following cryoprecipitate transfusion in platelet-type von Willebrand's disease.
Miller JL; Boselli BD; Kupinski JM
Blood; 1984 Jan; 63(1):226-30. PubMed ID: 6418233
[TBL] [Abstract][Full Text] [Related]
15. Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease.
Roussi J; Turecek PL; André P; Bonneau M; Pignaud G; Bal dit Sollier C; Schlokat U; Dorner F; Schwarz HP; Drouet L
Blood Coagul Fibrinolysis; 1998 Jun; 9(4):361-72. PubMed ID: 9690808
[TBL] [Abstract][Full Text] [Related]
16. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.
André P; Brouland JP; Roussi J; Bonneau M; Pignaud G; Bal dit Sollier C; Hainaud P; Vaiman M; Drouet L
Exp Hematol; 1998 Jul; 26(7):620-6. PubMed ID: 9657137
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.
Bowie EJ; Solberg LA; Fass DN; Johnson CM; Knutson GJ; Stewart ML; Zoecklein LJ
J Clin Invest; 1986 Jul; 78(1):26-30. PubMed ID: 3088043
[TBL] [Abstract][Full Text] [Related]
18. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.
Ching YN; Meyers KM; Brassard JA; Wardrop KJ
Am J Vet Res; 1994 Jan; 55(1):102-10. PubMed ID: 8141483
[TBL] [Abstract][Full Text] [Related]
19. Analysis of von Willebrand factor in platelets of patients with various forms of von Willebrand disease: is there a clinical relevance?
Kertzscher F; Müller AE; Lenk H
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S177-9. PubMed ID: 10650864
[TBL] [Abstract][Full Text] [Related]
20. Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease.
Gralnick HR; Rick ME; McKeown LP; Williams SB; Parker RI; Maisonneuve P; Jenneau C; Sultan Y
Blood; 1986 Jul; 68(1):58-61. PubMed ID: 3487361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
